Novartis Eyes China Community Hospital Market

China's health care reform which aims to maintain public health service is set to impact pharmaceutical MNCs. Foreign corporations are looking at community hospitals as a potential market, and Novartis has established a special institution that collaborates with community hospitals. The head of Novartis China believes local pharmaceutical companies will benefit more than MNCs from the reform, but the latter can still participate in basic health care with their generic drugs. China's immunity program expansion also brings business opportunities. Novartis is discussing with China National Biotec Group, China's key state vaccine manufacturer, on possible cooperation. (Click here for more - Chinese Language)